netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB Awards $5.4 Million In Grants to Support Eye Research

RPB awarded 36 grants totaling $5.4 million during its spring grant cycle. The latest awards include unrestricted grants to departments of ophthalmology at 17 medical schools across the United States and 19 awards to individual scientists.

RPB currently funds eye research at 41 medical institutions throughout the U.S., where RPB-supported laboratories investigate the entire spectrum of eye disease, from cataracts, glaucoma, and diabetic retinopathy to macular degeneration, retinitis pigmentosa and eye movement disorders. Among the newly funded investigations are: the development of a light-activated drug that potentially can arrest progressive ocular growth and macular stretching that occurs in degenerative myopia; the pursuit of less toxic alternatives to currently-used chemotherapy regimens in the treatment of retinoblastoma, an eye cancer that develops in babies; and the complete characterization of early neural changes in diabetics who do not yet show diabetic retinopathy symptoms.

Two new awards were given out as part of RPB's Low Vision Research initiative: one for the development of an economical and easy-to-use low vision screen magnifier that will enable scrolling control by means of the viewer's own gaze, rather than by using a mouse or trackpad; and one to develop new rehabilitation options for patients with cortical visual impairment, a leading cause of pediatric low vision. RPB will award additional grants in December.

Since it was founded in 1960, RPB has channeled more than $341 million into eye research.  As a result, RPB has been identified with nearly every major breakthrough in vision research in that time. 

Related News: Feature Story, Grants, Top Story

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

RPB and AAO Award Grants for Big Data Research to Advance Patient Care

Award recipients to use IRIS Registry database to conduct population-based studies.

Read More

 

Research to Prevent Blindness Expands Grants Program

Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.